IP40 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Innocan Pharma Corp

Watchlist Manager

Watchlist

Price: 1.17 EUR -4.1% Market Closed

Market Cap: €5.3m

	Innocan Pharma Corp F:IP40	IL
E	Enwell Energy PLC F:RHN	UK
A	AJ Plast PCL SET:AJ	TH
B	Bangkok Lab and Cosmetic PCL SET:BLC	TH
	First Phosphate Corp F:KD0	CA
S	Sonae - SGPS SA ELI:SON	PT
D	Dynasty Ceramic PCL SET:DCC	TH
D	DOD Biotech PCL SET:DOD	TH
P	Petchsrivichai Enterprise PCL SET:PCE	TH
T	TMT Steel PCL SET:TMT	TH
F	Forth Smart Service PCL SET:FSMART	TH
	STRABAG SE F:XD4	AT
E	Eco Oro Minerals Corp XMUN:GQQ	CA
T	Techlead Next PCL SET:TL	TH
	Bumi Benowo Sukses Sejahtera Tbk PT IDX:BBSS	ID
M	Mark2 Corporation Investment SE PSE:M2C	CZ

Profitability Summary

Innocan Pharma Corp's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

90%

Strong 3Y Average Gross Margin

89%

Declining Gross Margin

94% > 90%

Negative Operating Margin

-15%

Negative 3Y Average Operating Margin

-9%

Operating Margin is Increasing

-44% > -15%

Negative Net Margin

-4%

Negative 3Y Average Net Margin

-12%

Net Margin is Increasing

-51% > -4%

Negative Free Cash Flow Margin

-7%

Negative 3Y Average Free Cash Flow Margin

-7%

Free Cash Flow Margin is Increasing

-40% > -7%

Negative ROE

-21%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-38%

ROIC is Increasing

-202% > -91%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.